-
Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) is one of the most critical global public health challenges, particularly threatening the health of pregnant women living with HIV and their offspring. In 2022, among the 1.2 million pregnant women living with HIV globally, approximately 82% received antiretroviral drugs to prevent mother-to-child transmission (PMTCT) of HIV (1). Without intervention, mother-to-child transmission (MTCT) of HIV occurs at rates of 15%–45% (2), but antiretroviral therapy (ART) can reduce this to less than 2% (3). Yunnan Province, which first identified HIV infection among local drug users in China, has implemented the PMTCT for HIV Program since 2003, spanning more than two decades (4). In Yunnan, ART coverage increased substantially from 75.92% in 2006 to 99.72% in 2019, corresponding with a decrease in MTCT decreased from 8.78% to 1.93% during the same period (5).
Maternal HIV infection significantly elevates the risk of intrauterine death, with rates of 7.1% among HIV-positive pregnant women compared to 2.3% among HIV-negative pregnant women (6). Additionally, maternal HIV infection increases the risks of low birth weight and preterm birth (6-7), with 13.2% of live-born infants having low birth weight and 7.4% experiencing premature birth (6). Across seven African countries, HIV infection is associated with elevated preterm birth rates of 15%–20% of all pregnancies, varying notably by ART regimen (8). In China, preterm birth rates among women living with HIV were reported at 10.70% in Hubei province (9) and 14.70% in Guangxi province (10). However, research describing neonatal outcomes among HIV-positive pregnant women in Yunnan province, which has China’s highest HIV/AIDS prevalence, remains limited, and the impact of maternal ART on stillbirth and neonatal death requires further investigation in this region.
This study utilized data from the National Information System of Integrated Prevention of Mother-to-Child Transmission of HIV, Syphilis and Hepatitis B Program to evaluate the impact of maternal ART on stillbirth and neonatal death among HIV-positive pregnant women in Yunnan.
HTML
-
This study conducted a descriptive study analyzing data from the PMTCT system to evaluate the impact of maternal ART use among HIV-positive pregnant women in Yunnan Province, with data extraction performed on December 16, 2024. The study included all HIV-positive pregnant women from 2013–2022 in Yunnan Province, excluding those with multifetal pregnancies, unknown ART status, or infant deaths occurring after 28 days postpartum. The PMTCT system, established in 2007, captures comprehensive data including maternal demographics, infant characteristics, HIV transmission routes, ART regimens, and antenatal care utilization.
Our primary outcomes were stillbirth and neonatal mortality. The stillbirth rate (SBR) was defined as the number of babies born with or without signs of life at or after 28 weeks gestation per 1,000 total births. The neonatal mortality rate (NMR) was defined as deaths occurring within the first 28 days after birth per 1,000 total births.
ART during pregnancy was administered to reduce perinatal transmission. Two standardized regimens were used: the first comprised Zidovudine (AZT)–lamivudine (3TC)–lopinavir/ritonavir (LPV/r), and the second comprised of Tenofovir (TDF)–3TC–efavirenz (EFV).
Statistical analysis included descriptive statistics to characterize the study population and outcomes, stratified by maternal ART use. Chi-square tests were employed to assess differences in outcomes across education levels, marital status, ethnicity, and maternal ART use. Multivariate Poisson regression analysis was conducted to identify risk factors for stillbirth and newborn outcomes. All statistical analyses were performed using R packages stats and MASS, with statistical significance set at P<0.05.
The study was exempt from ethical review by the Ethics Review Committee of the National Center for Women and Children’s Health Chinese Center for Disease Control and Prevention, as the National Information System of Integrated Prevention of Mother-to-Child Transmission of HIV, Syphilis and Hepatitis B Program is a mandatory, legally supported public health surveillance system.
-
During 2013–2022, a total of 9,563 HIV-positive women pregnant with singleton pregnancies were identified in Yunnan province. The mean maternal age was 29.71 (±5.91) years, and 7,480 (78.22%) were less than 35 years old. Educational attainment varied: 1,347 (14.09%) were illiterate, and 3,048 (31.87%) had primary education. 4,696 (49.11%) had secondary education, and 472 (4.94%) had tertiary education. ART coverage was high, with 9,404 (98.34%) women receiving treatment. Of these, 8,220 (87.41%) initiated ART before pregnancy, 599 (6.40%) during pregnancy, 78 (0.83%) during delivery, and 507 (5.39%) after delivery. Only 159 (1.66%) women did not receive ART.
Table 1 presents the demographic and clinical characteristics of the study population stratified by ART use. Marital status (P=0.047), educational level, parity number of children, and antenatal care visits were significantly associated with ART utilization (P<0.001).
Characteristics Overall, n (%) No ART, n (%) ART, n (%) χ2, P Age (years) 0.00, 0.979 <35 7,480 (78.22) 125 (78.62) 7,355 (78.21) ≥35 2,083 (21.78) 34 (21.38) 2,049 (21.79) Ethnicity 0.02, 0.891 Han 4,670 (48.83) 79 (49.69) 4,591 (48.82) Other 4,893 (51.17) 80 (50.31) 4,813 (51.18) Marital status 0.047* Single 591 (6.18) 13 (8.18) 578 (6.15) Married 8,817 (92.20) 140 (88.05) 8,677 (92.27) Divorced/widowed 155 (1.62) 6 (3.77) 149 (1.58) Level of education 20.42, <0.001 Illiterate 1,347 (14.09) 32 (20.13) 1,315 (13.98) Primary 3,048 (31.87) 68 (42.77) 2,980 (31.69) Secondary 4,696 (49.11) 57 (35.85) 4,639 (49.33) Tertiary 472 (4.94) 2 (1.26) 470 (5.00) Parity 14.39, <0.001 Primiparity 3,178 (33.23) 30 (18.87) 3,148 (33.48) ≥1 6,385 (66.77) 129 (81.13) 6,256 (66.52) No. of child 19.98, <0.001 0 3,486 (36.45) 36 (22.64) 3,450 (36.69) 1 3,965 (41.46) 68 (42.77) 3,897 (41.44) ≥2 2,112 (22.09) 55 (34.59) 2,057 (21.87) Antenatal care visits 828.89, <0.001 0 516 (5.42) 89 (55.97) 427 (4.54) 1–5 4,151 (43.41) 57 (35.85) 4,094 (43.53) ≥6 4,896 (51.20) 13 (8.18) 4,883 (51.92) Total 9,563 (100.00) 159 (100.00) 9,404 (100.00) Abbreviation: ART=antiretroviral therapy.
* Fisher’s exact test.Table 1. Basic characteristics of HIV-positive pregnant women.
-
Among the study population, there were 9,421 live births, 76 stillbirths, and 66 neonatal deaths (Table 2), yielding an SBR of 8.07‰ and an NMR of 7.01‰. Poisson test analysis revealed a statistically significant difference in SBR between pregnant women who used ART and those who did not (P=0.033). However, no statistically significant difference was observed in NMR between these groups (P=0.088).
Characteristics Overall No Maternal ART Maternal ART P Live births 9,421 152 9,269 SBR (‰) 76 (8.07) 4 (26.32) 72 (7.77) 0.033 NMR (‰) 66 (7.01) 3 (19.74) 63 (6.80) 0.088 Abbreviation: ART=antiretroviral therapy; SBR=stillbirth rate; NMR=neonatal mortality rate. Table 2. Impact of ART on stillbirth and newborn outcomes.
-
Maternal age, marital status, education level, parity, and number of children were independently associated with newborn survival. Additionally, ART use (P=0.009), ethnicity (P=0.012), and antenatal care utilization (P<0.001) had demonstrated significant associations with stillbirth and newborn survival outcomes (Table 3).
Characteristics Live births, n (%) Death, n (%) χ2, P ART 0.009 No 152 (1.61) 7 (4.93) Yes 9,269 (98.39) 135 (95.07) Age (years) 0.82, 0.364 <35 7,364 (78.17) 116 (81.69) ≥35 2,057 (21.83) 26 (18.31) Ethnicity 6.30, 0.012 Han 4,616 (49.00) 54 (38.03) Other 4,805 (51.00) 88 (61.97) Marital status 0.133* Single 586 (6.22) 5 (3.52) Married 8,680 (92.13) 137 (96.48) Divorced/widowed 155 (1.65) 0 (0.00) Level of education 7.10, 0.069 Illiterate 1,319 (14.00) 28 (19.72) Primary 3,002 (31.86) 46 (32.39) Secondary 4,630 (49.15) 66 (46.48) Tertiary 470 (4.99) 2 (1.41) Parity 0.71, 0.400 Primiparity 3,136 (33.29) 42 (29.58) ≥1 6,285 (66.71) 100 (70.42) No. of child 3.97, 0.137 0 3,437 (36.48) 49 (34.51) 1 3,913 (41.53) 52 (36.62) ≥2 2,071 (21.98) 41 (28.87) Antenatal care visits 84.05, <0.001 0 497 (5.28) 19 (13.38) 1–5 4,048 (42.97) 103 (72.54) ≥6 4,876 (51.76) 20 (14.08) Total 9,421 (100.00) 142 (100.00) Abbreviation: ART=antiretroviral therapy.
* Fisher’s exact test.Table 3. Independent associations with stillbirth and newborn outcomes and relevant factors.
Multivariate Poisson regression analysis revealed that ART use, ethnicity, and parity were independent risk factors for stillbirth and neonatal mortality. Notably, compared to women who received no antenatal care, those who attended six or more antenatal care visits showed significantly reduced risk of stillbirth and neonatal mortality [odds ratio (OR)=0.13] (Table 4).
Characteristics Estimate (95% CI) OR (95% CI) SE Z value P Intercept −3.11 (−3.99, −2.40) 0.04 (0.02,0.09) 0.40 −7.74 <0.001 ART No Reference Reference Reference Yes −0.48 (−1.30, 0.42) 0.62 (0.29, 1.52) 0.42 −1.16 0.247 Ethnicity Han Reference Reference Reference Others 0.30 (−0.03, 0.65) 1.35 (0.97, 1.91) 0.17 1.75 0.081 Antenatal care visits 0 Reference Reference Reference 1−5 −0.29 (−0.79, 0.27) 0.75 (0.45, 1.30) 0.27 −1.09 0.274 ≥6 −2.06 (−2.72, −1.39) 0.13 (0.07, 0.25) 0.34 −6.13 <0.001 Abbreviation: CI=confidence intervals; OR=odds ratio; SE=standard error; ART=antiretroviral therapy. Table 4. Risk factors of stillbirth and the outcomes of newborn by multivariate Poisson regression.
Survival of HIV-exposed Newborns
Impact on Stillbirth and Newborn Outcomes
-
The health outcomes of infants born to HIV-infected mothers are crucial for promoting newborn health and evaluating mother-to-child transmission prevention efforts. Our analysis of surveillance data examined the impact of maternal ART use during pregnancy on adverse pregnancy and newborn outcomes among women living with HIV. In accordance with China’s technical guidelines for PMTCT of HIV, Syphilis, and Hepatitis B, newborns have not yet received an HIV diagnosis. Our study primarily evaluated two major health conditions: stillbirth as an adverse pregnancy outcome and neonatal death (within 28 days of birth) as an adverse newborn outcome. This study found significantly higher stillbirth rates among mothers who did not use ART during pregnancy compared to those who did, highlighting the critical importance of ART adherence in this vulnerable population.
Neonatal mortality serves as a crucial indicator of maternal and child health. Yunnan province has a substantial population of HIV-positive pregnant women, with both crude HIV-positivity rates and the proportion of subsequent pregnancies among HIV-positive women showing consistent annual increases between 2006 and 2019 (11). Consequently, the number of infants born to mothers living with HIV is projected to rise. Previous research has demonstrated that HIV-exposed but uninfected infants, compared to HIV-unexposed infants, experience poorer health outcomes and may face impaired physical and neurological development (12–13). These findings underscore the need for enhanced neonatal healthcare and the development of targeted interventions to improve child health outcomes.
Our findings suggest that HIV exposure may increase the probability of stillbirth in pregnancies of women living with HIV. Comparative data from India showed a significantly higher SBR among HIV-infected women (26.7‰, 93/3,478) compared to the national average (5‰) (14). Similarly, in Zambia, a stillbirth rate of 26 per 1,000 live births was reported among 1,229 HIV-infected pregnant women (15). While our study revealed lower stillbirth rates among HIV-infected women (8.07‰) compared to these international studies, the statistically significant difference in stillbirth rates between ART users (26.32‰) and non-users (7.77‰) remained.
Notably, multivariable Poisson regression analysis did not identify ART use as independently associated with adverse pregnancy outcomes. The discrepancy between chi-square testing and multivariable regression results may be attributed to several factors. First, the single stillbirth case among pregnant women who did not use ART could represent a random occurrence. Second, when controlling for ethnicity, parity, and antenatal care visits in the multivariable Poisson regression, the differences in SBR and NMR between ART users and non-users became non-significant at certain variable levels. The regression results demonstrated that women with six or more antenatal care visits had a lower risk of adverse pregnancy outcomes compared to those without any visits, emphasizing the importance of regular antenatal care.
Our study has limitations. As a descriptive analysis focusing solely on mortality, we did not examine other health aspects of infants born to HIV-positive women. There is an urgent need for in-depth analysis of specific causes of death and comprehensive evaluation of health conditions beyond survival. Future research should prioritize both psychological and physiological studies in this population.
The stillbirth and neonatal mortality rates were significantly higher among HIV-positive mothers who did not receive ART during pregnancy compared to those who received ART. Healthcare interventions for HIV-positive pregnant women warrant increased attention to ensure universal ART coverage and to address modifiable risk factors associated with stillbirth and neonatal mortality through targeted preventive measures.
-
The valuable contributions of PMTCT staff members from local Maternal and Child Health Care Hospitals, Centers for Disease Control and Prevention, and general hospitals for their assistance with data collection.
-
The study was exempt from ethical review by the Ethics Review Committee of National Center for Women and Children’s Health Chinese Center for Disease Control and Prevention.
Citation: |